Eric Burak
2021
In 2021, Eric Burak earned a total compensation of $3M as Chief Scientific Officer at Fusion Pharmaceuticals, a 62% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $166,164 |
---|---|
Option Awards | $2,308,284 |
Salary | $458,549 |
Other | $23,599 |
Total | $2,956,597 |
Burak received $2.3M in option awards, accounting for 78% of the total pay in 2021.
Burak also received $166.2K in non-equity incentive plan, $458.5K in salary and $23.6K in other compensation.
Rankings
In 2021, Eric Burak's compensation ranked 4,484th out of 12,412 executives tracked by ExecPay. In other words, Burak earned more than 63.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,484 | 64th |
Manufacturing | 1,844 | 67th |
Chemicals And Allied Products | 768 | 68th |
Drugs | 683 | 67th |
Biological Products, Except Diagnostic Substances | 172 | 62nd |
Burak's colleagues
We found two more compensation records of executives who worked with Eric Burak at Fusion Pharmaceuticals in 2021.